Linden Advisors’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

Linden Advisors’s Portfolio ORIAW Stock Details ORIAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-139,998	Closed	-$9.1K	–	485
2023 Q1	$9.1K	Hold	139,998	–	–	﹤0.01%	433
2022 Q4	$24.9K	Hold	139,998	–	–	﹤0.01%	448
2022 Q3	$26K	Hold	139,998	–	–	﹤0.01%	579
2022 Q2	$27K	Hold	139,998	–	–	﹤0.01%	639
2022 Q1	$54K	Buy	+139,998	New	+$72.2K	﹤0.01%	653

Linden Advisors's ORIAW Position: Q2 2023 in Review

Linden Advisors sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q2 2023, closing a stake of 139,998 shares — an estimated $9.1K sold.

Linden Advisors first reported a position in ORIAW in Q1 2022 and held it in 5 quarters. The position peaked at $54K in Q1 2022. 0 funds tracked by Wall St. Rank hold ORIAW as of Q2 2023.

Linden Advisors reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q2 2023 after selling out during the quarter.
Linden Advisors sold 139,998 Orion Biotech Opportunities Corp. Warrant shares in Q2 2023, an estimated $9.1K.
Linden Advisors first reported a position in Orion Biotech Opportunities Corp. Warrant in Q1 2022 and held it in 5 quarters.
Linden Advisors's Orion Biotech Opportunities Corp. Warrant position peaked at $54K in Q1 2022.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q2 2023.

Based on Linden Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.